Cargando…

Neonatal pulmonary hypertension in mitochondrial disorders due to TMEM70 mutations

Detalles Bibliográficos
Autores principales:	Finsterer, Josef, Kothari, Sonam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121287/ https://www.ncbi.nlm.nih.gov/pubmed/27896093 http://dx.doi.org/10.1016/j.ymgmr.2014.04.009

Ejemplares similares

Primary Pulmonary Hypertension as a Manifestation of Adult Multi-System Mitochondrial Disorder
por: Finsterer, Josef
Publicado: (2009)

Mitochondrial cardioencephalopathy due to a COQ4 mutation
por: Finsterer, Josef, et al.
Publicado: (2017)

Mitochondrial multiorgan disorder syndrome (MIMODS) due to a compound heterozygous mutation in the ACAD9 gene()
por: Finsterer, Josef, et al.
Publicado: (2017)

Confusion in connection with pulmonary hypertension due to premature ventricular complexes requires diagnostic work-up
por: Finsterer, Josef
Publicado: (2023)

Diabetes due to Mitochondrial Adipopathy
por: Finsterer, Josef, et al.
Publicado: (2017)

Mitochondrial Ophthalmoplegia Is Not Only due to mtDNA Deletions
por: Finsterer, Josef
Publicado: (2019)

Autism spectrum disorder: A mitochondrial disorder
por: FINSTERER, Josef
Publicado: (2021)

Autosomal Recessive Mitochondrial Myopathy due to MICU-1 Variants
por: Finsterer, Josef
Publicado: (2023)

Mitochondrial disorders due to m.3243A>G not meeting diagnostic criteria for MELAS require comprehensive work-up
por: Finsterer, Josef, et al.
Publicado: (2023)

Mitochondrial disorders are prone to propofol infusion syndrome
por: Finsterer, Josef
Publicado: (2020)

The Spectrum of Renal Abnormalities in Mitochondrial Disorders Is Broad
por: Finsterer, Josef
Publicado: (2022)

Mitochondrial myopathy plus due to the variant m.586G > A in MT-TF
por: Finsterer, Josef
Publicado: (2019)

The spectrum of neuro-ophthalmologic involvement in mitochondrial disorders is broad
por: Finsterer, Josef
Publicado: (2021)

Genotypic and Phenotypic Heterogeneity of LGMD1D due to DNAJB6 Mutations
por: Finsterer, Josef
Publicado: (2018)

Costs for mitochondrial medicine will remain high as long as mitochondrial disorders are misdiagnosed()()()()
por: Finsterer, Josef, et al.
Publicado: (2017)

Pulmonary hypertension may be secondary in carriers of compound heterozygous FOXRED1 variants
por: Finsterer, Josef
Publicado: (2019)

Doping May Be Responsible forDe Novo Mitochondrial Disorder
por: Finsterer, Josef
Publicado: (2019)

Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS) due to a m.10158T>C ND3 Mutation with a Normal Muscle Biopsy
por: Finsterer, Josef, et al.
Publicado: (2017)

POLG1-related Mitochondrial Disorder with MNGIE- and Leigh-like Features
por: Finsterer, Josef
Publicado: (2020)

Letter to the Editor: Endocrine Compromise in Mitochondrial Disorders
por: Finsterer, Josef, et al.
Publicado: (2018)

Comment on “Role of Mitochondrial Genome Mutations in Pathogenesis of Carotid Atherosclerosis”
por: Finsterer, Josef, et al.
Publicado: (2018)

Arterial hypertension in Leigh syndrome due to m.13513G > A is multicausal, requiring an extensive search to identify its pathphysiology
por: Finsterer, Josef
Publicado: (2023)

Aseptic meningitis as a manifestation of a mitochondrial disorder
por: Finsterer, Josef, et al.
Publicado: (2016)

Does growth-hormone treatment affect patients with and without a mitochondrial disorder differentially?
por: Finsterer, Josef
Publicado: (2018)

MicroRNAs are inappropriate for characterising hearing impairment in mitochondrial disorders
por: Finsterer, Josef, et al.
Publicado: (2018)

Multisystem mitochondrial disorder is more prevalent than BGC1 variants in patients with Fahr's syndrome
por: Finsterer, Josef
Publicado: (2019)

Diagnosing mitochondrial, neurogastrointestinal leukoencephalopathy requires mutations in TYMP1, POLG1, LIG1, or RRM2B
por: Finsterer, Josef
Publicado: (2023)

ATP Synthase Deficiency due to TMEM70 Mutation Leads to Ultrastructural Mitochondrial Degeneration and Is Amenable to Treatment
por: Braczynski, Anne K., et al.
Publicado: (2015)

Treating mitochondrial disorders requires full exploitation of available therapeutic options
por: Finsterer, Josef, et al.
Publicado: (2017)

Comment on “Mitochondrial Neurogastrointestinal Encephalomyopathy: Novel Pathogenic Mutation in Thymidine Phosphorylase Gene in a Patient from Cape Verde Islands”
por: Finsterer, Josef
Publicado: (2021)

Lethal Neonatal CoQ Deficiency due to a COQ9 Variant
por: Finsterer, Josef, et al.
Publicado: (2018)

Traumatic brain injury is unlikely precipitating Leigh syndrome due to the GJB2 mutation c.35delG
por: Finsterer, Josef, et al.
Publicado: (2017)

Comment on “Proximal Myopathy due to m.5835G>A Mutation in Mitochondrial MT-TY Gene”
por: Finsterer, J., et al.
Publicado: (2019)

Anti-mitochondrial antibody–mediated myopathy with cardiac involvement
por: Finsterer, Josef
Publicado: (2023)

Camptocormia due to myotinilopathy, Parkinson’s disease, or both?: Camptocormia and axial myopathy
por: Finsterer, Josef
Publicado: (2023)

Pregnancy reduces severity and frequency of attacks in hyperkalemic periodic paralysis due to the mutation c.2111C>T in the SCN4A gene
por: Finsterer, Josef, et al.
Publicado: (2017)

Genotype–Phenotype Correlations in MPAN Due to C19orf12 Variants
por: Finsterer, Josef
Publicado: (2021)

Valproate Is Contraindicated in POLG1 Mutations
por: Finsterer, Josef
Publicado: (2019)

TK2-related mitochondrial disorder is not restricted to the skeletal muscle
por: Finsterer, Josef, et al.
Publicado: (2018)

Sudden death in SARS-CoV-2 associated polyradiculitis is unlikely due to affection of the phrenic nerve
por: Finsterer, Josef
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4p61f2lbm6r07bsrg3ei6jt3mp